New treatment against drug-resistant TB successful

Multidrug-resistant TB is a serious public health challenge. It affects vulnerable communities such as migrant workers, refugees, prisoners and …

FDA approves new oral three-drug regimen for extensively drug-resistant TB

The treatment involves pretomanid tablets in combination with bedaquiline and linezolid, collectively referred to as the BPaL regimen, and has an …

Gains in tuberculosis control threatened by drug resistance

Drug resistant TB is now a transmitted diseases and requires commitment, especially in high-burden countries like India 

The new tuberculosis drug is effective, but unaffordable

The drug "delamanid" is not registered in countries with high tuberculosis rates, limiting its access

Antibiotic resistance: South Africa has a success story in treating resistant TB

Antimicrobial resistance is a worry as in several other African countries  

India tops nations burdened by TB

Absence of new drugs and vaccines, funds shortage affecting treatment and control

Vitamin C could be panacea for drug-resistant TB

Vitamin triggers reaction which eventually kills off bacteria; could help shorten drug therapy

Tuberculosis control in India: towards universal access

Revised TB control programme needs to evolve an inclusive business model to engage the Indian private sector to ensure better quality of TB care

Totally drug resistant TB: government in denial mode

Health ministry deputes team to Mumbai; says neither WHO nor tuberculosis control programme recognise TDR-TB